Prevention of venous thrombosis in medical patients;Prevention de la thrombose veineuse profonde en medecine

Annales de Medecine Interne

Volumn 151, Issue 3, 2000, Pages 207-214

  Bergmann, Jean François ^a   Mahe, Isabelle ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Deep vein thrombosis; Low molecular weight heparin; Prevention

Indexed keywords

DEEP VEIN THROMBOSIS; HEART FAILURE; HEART INFARCTION; HUMAN; PROPHYLAXIS; REVIEW; SEPSIS; STROKE; VEIN THROMBOSIS; HOSPITALIZATION; RISK ASSESSMENT; RISK FACTOR;

HOSPITALIZATION; HUMANS; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOSIS;

EID: 0033917393     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. INTERNATIONAL CONSENSUS STATEMENT: Prevention of venous thromboembolism. Int Angiol, 1997: 16: 3-38.
2. CLAGETT GP, ANDERSON FA Jr, GEERT W, et al.: Prevention of venous thromboembolism. Chest. 1998; 114: 531S-560S.
3. THRIFT CONSENSUS GROUP: Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ, 1992; 305: 567-73.
4. Prophylaxie des thromboses veineuses postopératoires : recommandations de l'Assistance Publique-Hôpitaux de Paris. STV, 1995; 7: 119-20.
5. BERGMANN JF, ELKHARRAT D: Prevention of venous thromboembolic risk in non-surgical patients. Haemostasis, 1996; 26 (Suppl 2): 16-23.
6. BERGMANN JF, KEVORKIAN JP, CHASSANY O : Synthèse : certitudes/incertitudes pour la prévention de la thrombose veineuse en médecine. Thérapie, 1998 ; 53: 571-4.
7. FIESSINGER JN, CHATELLIER G : Évaluation d'une intervention sur la prescription et la surveillance biologique des héparines de bas poids moléculaire en médecine. Presse Med, 1996; 25: 1777-80.
8. VERSTRAETE M: Prophylaxis of venous thromboembolism. BMJ, 1997; 314: 123-5.
9. SANDERCOCK P, LINDLEY R, WARDLOW J: Antiplatelet, anticoagulant and fibrinolytic agents in acute ischaemic stroke and TIA. Review Br J Hosp Med, 1992; 47: 731-7.
10. LEVINE M, HIRSH J, GENT M, et al.: Double-blind randomized trial of very low dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet, 1994; 343: 886-9.
11. BERN M, LOKICH JJ, WALLACH SR, et al.: Very low doses of warfarin can prevent thrombosis in central venous catheters: a randomized propective trial. Ann Intern Med, 1990; 112: 423-8.
12. MONTREAL M, ALASTRUE A, RULL M, et al.: Upper extremity deep vein thrombosis in cancer patients with venous access devices: prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost, 1996; 75: 251-3.
13. BELCH JJ, LOWE GDO, WARD AG, et al.: Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J, 1981; 26: 115-7.
14. CADE JF: High risk of the critically ill for venous thromboembolism. Crit Care Med, 1982; 10: 448-50.
15. HALKIN H, GOLDBERG J, MODAN M, et al.: Reduction of mortality in general medical inpatients by low dose heparin. Ann Intern Med, 1982; 96: 561-5.
16. DAHAN R, HOULBERT D, CAULIN C, et al.: Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: a randomized double-blind trial. Haemostasia, 1986; 16: 159-64.
17. BERGMANN JF, CAULIN C: Heparin prophylaxis in bedridden patients. Lancet, 1996; 348: 205-6.
18. GARDLUND B: Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. Lancet. 1996; 347: 1357-61.
19. SAMAMA MM, COHEN AT, DARMON JY, et al.: A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med, 1999; 341: 793-800.
20. BERGMANN JF : Prévention de la thrombose veineuse profonde : Homans, le retour ? STV, 1998 ; 10: 203-5.
21. LEDERLE TA: Heparin prophylaxis for medical patients. Ann Intern Med 1998; 128: 768-70.
22. LÉVESQUE H, MARIE I, CAILLEUX N, HANTUTE N, COURTOIS H : Coût des héparines de bas poids moléculaire utilisées en prophylaxie ou en traitement curatif de la maladie thromboembolique. Rev Med Interne, 1997 ; 18 (Suppl 6) : 651s-6s.